Dr. Thomas LeBlanc on Patient Shared Decision-Making in Hematologic Malignancies
October 2nd 2016Thomas LeBlanc, MD, assistant professor of medicine, Duke Cancer Institute, discusses why it is important to include patients in the decision-making process for the treatment of hematologic malignancies.
Read More